CNS5:Pleomorphic xanthoastrocytoma: Difference between revisions
| Line 109: | Line 109: | ||
|EGFR not typically amplified) | |EGFR not typically amplified) | ||
|D | |D | ||
|No (however, frequently mentioned in literature as a recurrent copy number change in PXA ( | |No (however, frequently mentioned in literature as a recurrent copy number change in PXA<ref>{{Cite journal|last=Vaubel|first=Rachael|last2=Zschernack|first2=Valentina|last3=Tran|first3=Quynh T.|last4=Jenkins|first4=Sarah|last5=Caron|first5=Alissa|last6=Milosevic|first6=Dragana|last7=Smadbeck|first7=James|last8=Vasmatzis|first8=George|last9=Kandels|first9=Daniela|date=2021-01|title=Biology and grading of pleomorphic xanthoastrocytoma-what have we learned about it?|url=https://pmc.ncbi.nlm.nih.gov/articles/PMC8018001/|journal=Brain Pathology (Zurich, Switzerland)|volume=31|issue=1|pages=20–32|doi=10.1111/bpa.12874|issn=1750-3639|pmc=8018001|pmid=32619305}}</ref> | ||
|Trisomy, supports diagnosis; also seen in other gliomas | |Trisomy, supports diagnosis; also seen in other gliomas | ||
|- | |- | ||